Cargando…
Inhibition of Tet1- and Tet2-mediated DNA demethylation promotes immunomodulation of periodontal ligament stem cells
Periodontal ligament stem cells (PDLSCs) possess great potential for clinical treatment of immune diseases due to their extensive immunomodulatory properties. However, the underlying mechanisms that govern the immunomodulatory properties of mesenchymal stem cells (MSCs) are still not fully elucidate...
Autores principales: | Yu, Tingting, Liu, Dawei, Zhang, Ting, Zhou, Yanheng, Shi, Songtao, Yang, Ruili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791886/ https://www.ncbi.nlm.nih.gov/pubmed/31611558 http://dx.doi.org/10.1038/s41419-019-2025-z |
Ejemplares similares
-
Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter
por: Yang, Ruili, et al.
Publicado: (2018) -
TET family dioxygenases and DNA demethylation in stem cells and cancers
por: An, Jungeun, et al.
Publicado: (2017) -
Hydrogen sulfide promotes immunomodulation of gingiva-derived mesenchymal stem cells via the Fas/FasL coupling pathway
por: Yang, Ruili, et al.
Publicado: (2018) -
TET proteins and the control of cytosine demethylation in cancer
por: Scourzic, Laurianne, et al.
Publicado: (2015) -
TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression
por: Okashita, Naoki, et al.
Publicado: (2019)